Related Experiment Video
Updated: Jan 24, 2026

HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis
Published on: June 24, 2019
MSCs inhibits the angiogenesis of HUVECs through the miR-211/Prox1 pathway
Jian Pan1, Xianglong Wang1, Dequan Li2
1Department of Ophthalmology, The First Affiliated Hospital of Wenzhou Medical University, Nanbaixiang, Ouhai District, Wenzhou, Zhejiang, China.
Abstract:
The aim of this study was to investigate the effect of mesenchymal stem cells (MSCs) on the angiogenesis of human umbilical vein endothelial cells (HUVECs). MSCs were subconjunctival injected into rat corneal alkali burn models. Their impacts on the degree of corneal neovascularization (CNV) and corneal opacity were evaluated at 3, 6, 9 and 12 days after injection. An in vitro experiment of MSCs affecting HUVECs angiogenesis was performed and evaluated using the tube formation assay. The results showed that both CNV and corneal opacity were decreased in rats after MSCs injection. In HUVECs, angiogenesis of cells was inhibited by miR-211 overexpression. miR-211 negatively regulated Prox1 expression. Knockdown of miR-211 blocked the decrease of Prox1 expression induced by MSCs and the inhibitory effect of MSCs on the angiogenesis of HUVECs. The critical role of miR-211 in MSCs inhibition of corneal angiogenesis was confirmed in rat experiments. We concluded that MSCs inhibited the angiogenesis of HUVEC through miR-211 mediating the down-regulation of Prox1.
Insights
Mesenchymal stem cells (MSCs) reduce corneal neovascularization and opacity by inhibiting human umbilical vein endothelial cells (HUVECs) angiogenesis. This effect is mediated by miR-211, which down-regulates Prox1 expression.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Molecular Biology
Background:
- Corneal neovascularization (CNV) is a significant cause of vision impairment.
- Mesenchymal stem cells (MSCs) show therapeutic potential in ocular surface diseases.
- Understanding the molecular mechanisms of MSCs in controlling angiogenesis is crucial.
Purpose of the Study:
- To investigate the effect of MSCs on angiogenesis of human umbilical vein endothelial cells (HUVECs).
- To elucidate the role of miR-211 and Prox1 in MSC-mediated inhibition of corneal angiogenesis.
Main Methods:
- Subconjunctival injection of MSCs in a rat corneal alkali burn model.
- Evaluation of corneal neovascularization (CNV) and opacity.
- In vitro tube formation assay using HUVECs.
- Assessment of miR-211 and Prox1 expression levels.
Main Results:
- MSCs significantly reduced CNV and corneal opacity in rats.
- MSC treatment inhibited HUVECs angiogenesis in vitro.
- miR-211 overexpression suppressed HUVECs angiogenesis by down-regulating Prox1.
- Knockdown of miR-211 reversed the inhibitory effects of MSCs on HUVECs angiogenesis and Prox1 expression.
Conclusions:
- MSCs inhibit HUVECs angiogenesis through the miR-211/Prox1 pathway.
- miR-211 plays a critical role in MSC-mediated inhibition of corneal angiogenesis.
- This study reveals a novel mechanism for MSCs in treating corneal neovascularization.
Related Concept Videos
Feedback Inhibition
Mechanism of Angiogenesis
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Enzyme Inhibition
Other Glycolytic Pathways
Regulation of Angiogenesis and Blood Supply

